These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7772478)

  • 1. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer.
    Verhaegh ME; Sanders CJ; Arends JW; Neumann HA
    Br J Dermatol; 1995 May; 132(5):740-4. PubMed ID: 7772478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. bcl-2 expression in epidermal keratinocytic diseases.
    Nakagawa K; Yamamura K; Maeda S; Ichihashi M
    Cancer; 1994 Sep; 74(6):1720-4. PubMed ID: 8082073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and localization of bcl-2 protein in normal skin and in non-melanoma skin cancers.
    Rodriguez-Villanueva J; Colome MI; Brisbay S; McDonnell TJ
    Pathol Res Pract; 1995 Jun; 191(5):391-8. PubMed ID: 7479356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bcl-2 expression in primary malignancies of the skin.
    Morales-Ducret CR; van de Rijn M; LeBrun DP; Smoller BR
    Arch Dermatol; 1995 Aug; 131(8):909-12. PubMed ID: 7632062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer.
    Delehedde M; Cho SH; Sarkiss M; Brisbay S; Davies M; El-Naggar AK; McDonnell TJ
    Cancer; 1999 Apr; 85(7):1514-22. PubMed ID: 10193941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas.
    Smoller BR; Van de Rijn M; Lebrun D; Warnke RA
    Br J Dermatol; 1994 Jul; 131(1):28-31. PubMed ID: 8043419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal-cell carcinoma.
    Cerroni L; Kerl H
    J Cutan Pathol; 1994 Oct; 21(5):398-403. PubMed ID: 7868750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAX protein is not expressed by basal cell carcinomas.
    Rossen K; Karabulut Thorup A; Hou-Jensen K; Krag Jacobsen G
    Br J Dermatol; 1998 Sep; 139(3):472-4. PubMed ID: 9767293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
    Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
    Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax expression and growth behavior of basal cell carcinomas.
    Tilli CM; Stavast-Koey AJ; Ramaekers FC; Neumann HA
    J Cutan Pathol; 2002 Feb; 29(2):79-87. PubMed ID: 12150137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunohistochemical characteristics of the basosquamous cell carcinoma.
    Jones MS; Helm KF; Maloney ME
    Dermatol Surg; 1997 Mar; 23(3):181-4. PubMed ID: 9145960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratoacanthoma: a deficient squamous cell carcinoma? Study of bcl-2 expression.
    Sleater JP; Beers BB; Stephens CA; Hendricks JB
    J Cutan Pathol; 1994 Dec; 21(6):514-9. PubMed ID: 7699118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2-related proteins, alpha-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas.
    Bozdogan O; Erkek E; Atasoy P; Koçak M; Birol A; Caydere M
    Acta Derm Venereol; 2002; 82(6):423-7. PubMed ID: 12575847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers.
    Tomková H; Fujimoto W; Arata J
    Eur J Dermatol; 1998 Jun; 8(4):256-60. PubMed ID: 9649682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the bcl-2 oncogene in human basal cell carcinoma.
    Crowson AN; Magro CM; Kadin ME; Stranc M
    Hum Pathol; 1996 Apr; 27(4):355-9. PubMed ID: 8617478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases.
    Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y
    Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
    Ramdial PK; Madaree A; Reddy R; Chetty R
    J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours.
    Fuller LC; Allen MH; Montesu M; Barker JN; Macdonald DM
    Br J Dermatol; 1996 Jan; 134(1):28-32. PubMed ID: 8745882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.